Skeljungur hf.
The board of directors of Skeljungur hf. has made a decision to assess the advantages of future ownership of P/F Magn, Skeljungur’s subsidiary in the Faroe Islands. The internal organisation of P/F Magn will be scrutinised to evaluate whether Skeljungur’s advantages lie in external or organic growth or in selling the company, in part or in full.
Skeljungur will be advised by a corporate advisory team from Kvika Bank hf.
P/F Magn operates 11 retail and fuel outlets across the Faroe Islands, addition to operating two fuel depots and distributing fuel to corporations, contractors and fisheries operators. Magn leads the market in sales of fuel for house heating in the Faroe Islands, where most housing is heated using oil. Following the acquisition by Magn of the company P/F Demich, which specialises in environmentally sound house heating solutions, Magn will be able to offer comprehensive house heating solutions regardless of the energy chosen by customers for their heating.
P/F Magn’s total income in the operating year 2020 amounted to ISK 15,560 million, while the Group total income amounted to ISK 41,203 million. P/F Magn’s EBITDA in 2020 amounted to ISK 1,509 million, while the Group EBITDA amounted to ISK 2,676 million.
Further news may be expected in the coming months.
For further information, please contact Árni Pétur Jónsson, CEO fjarfestar@skeljungur.is.
www.skeljungur.is
https://www.linkedin.com/company/skeljungur-hf/
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Jeito Capital21.5.2025 07:05:00 CEST | Press release
Jeito Capital Leads a USD 65 million Financing in ReproNovo to Develop Transformational Treatments in Reproductive Medicine and Women’s Health
Augustine Therapeutics21.5.2025 07:00:00 CEST | Press release
Augustine Therapeutics appoints Rie Schultz Hansen, PhD as Chief Scientific Officer and establishes Copenhagen-based subsidiary
Idorsia Pharmaceuticals Ltd21.5.2025 07:00:00 CEST | Press release
New funds secured – allowing the commercial ramp-up of QUVIVIQ to accelerate Idorsia’s path to profitability
Orion Oyj21.5.2025 06:30:00 CEST | Press release
Orion’s collaborator, MSD, expands clinical development program for opevesostat to women’s cancers
CoinShares International Limited21.5.2025 06:30:00 CEST | Press release
CoinShares Expands XBT Provider Platform with Seven New Physical Crypto ETPs
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom